Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Revenue Estimates

This quarterly report represents an earnings surprise of 57.50%. A quarter ago, it was expected that this company would post a loss of $0.28 per share when it actually produced a loss of$0.54, delivering a surprise of -92.86%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Immunome, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.03 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 74.28% ...